feed,title,long_url,short_url
Motley,"Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters",https://www.fool.com/investing/2024/08/17/eli-lillys-top-glp-1-drugs-now-account-for-nearly/?source=iedfolrf0000001,https://da.gd/W5kSKR
